The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1-methyl-1H-pyrazol-4-yl)-3-(3-(piperidin-4-yl)phenyl)furo[3,2-b]pyridine ID: ALA4791451
PubChem CID: 162670405
Max Phase: Preclinical
Molecular Formula: C22H22N4O
Molecular Weight: 358.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2ccc3occ(-c4cccc(C5CCNCC5)c4)c3n2)cn1
Standard InChI: InChI=1S/C22H22N4O/c1-26-13-18(12-24-26)20-5-6-21-22(25-20)19(14-27-21)17-4-2-3-16(11-17)15-7-9-23-10-8-15/h2-6,11-15,23H,7-10H2,1H3
Standard InChI Key: YEFYCSKFDBXSSK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
16.8170 -3.9291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8159 -4.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5239 -5.1576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5222 -3.5202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2308 -3.9255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2356 -4.7441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0156 -4.9925 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4930 -4.3274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0078 -3.6680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1092 -3.5214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0236 -2.7087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2242 -2.5390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8157 -3.2469 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3628 -3.8539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8916 -1.7926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2563 -2.8931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0559 -2.7195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3040 -1.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7534 -1.3367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9515 -1.5147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7072 -2.2924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1007 -1.7676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6505 -2.3736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4483 -2.1999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6973 -1.4207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1424 -0.8150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3468 -0.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
1 10 1 0
12 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
9 16 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 22 1 0
18 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.45Molecular Weight (Monoisotopic): 358.1794AlogP: 4.36#Rotatable Bonds: 3Polar Surface Area: 55.88Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.06CX LogP: 3.51CX LogD: 0.96Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.59Np Likeness Score: -0.82
References 1. Němec V,Maier L,Berger BT,Chaikuad A,Drápela S,Souček K,Knapp S,Paruch K. (2021) Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine core., 215 [PMID:33636538 ] [10.1016/j.ejmech.2021.113299 ]